<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">OJGas</journal-id><journal-title-group><journal-title>Open Journal of Gastroenterology</journal-title></journal-title-group><issn pub-type="epub">2163-9450</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/ojgas.2019.93008</article-id><article-id pub-id-type="publisher-id">OJGas-91698</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine&amp;Healthcare</subject></subj-group></article-categories><title-group><article-title>
 
 
  Indications, Yield and Outcome of Colonoscopy: A 7-Year Retrospective Study in a Resource-Limited Setting
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Gabin</surname><given-names>Ulrich Kenfack</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Servais</surname><given-names>Albert Fiacre Bagnaka Eloumou</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Winnie</surname><given-names>Tatiana Bekolo Nga</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Guy</surname><given-names>Sadeu Wafeu</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Paul</surname><given-names>Nkemtendong Tolefac</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Agnès</surname><given-names>Malongue</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Mathurin</surname><given-names>Pierre Kowo</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Christian</surname><given-names>Tzeuton</given-names></name><xref ref-type="aff" rid="aff5"><sup>5</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Firmin</surname><given-names>Ankouane Andoulo</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Oudou</surname><given-names>Njoya</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Henry</surname><given-names>Namme Luma</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Dominique</surname><given-names>Noah Noah</given-names></name><xref ref-type="aff" rid="aff6"><sup>6</sup></xref></contrib></contrib-group><aff id="aff2"><addr-line>Faculty of Medicine and Pharmaceutical Sciences, The University of Douala, Douala, Cameroon</addr-line></aff><aff id="aff5"><addr-line>“Les Capucines” Medical Center, Douala, Cameroon</addr-line></aff><aff id="aff3"><addr-line>Faculty of Medicine and Biomedical Sciences, The University of Yaoundé I, Yaoundé, Cameroon</addr-line></aff><aff id="aff6"><addr-line>Deido District Hospital, Douala, Cameroon</addr-line></aff><aff id="aff4"><addr-line>Internal Medicine Unit, Douala General Hospital, Douala, Cameroon</addr-line></aff><aff id="aff1"><addr-line>Research Laboratory on Viral Hepatitis and Health Communication, Yaoundé, Cameroon</addr-line></aff><pub-date pub-type="epub"><day>10</day><month>04</month><year>2019</year></pub-date><volume>09</volume><issue>03</issue><fpage>49</fpage><lpage>58</lpage><history><date date-type="received"><day>11,</day>	<month>January</month>	<year>2019</year></date><date date-type="rev-recd"><day>27,</day>	<month>March</month>	<year>2019</year>	</date><date date-type="accepted"><day>30,</day>	<month>March</month>	<year>2019</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  <b>Background and Aims:</b> Diagnostic colonoscopy allows exploration of the colonic mucosa. Indications are multiple. The purpose of this work was to describe the indications and to report the lesions observed during colonoscopy at the General Hospital of Douala. 
  <b>Methods:</b> This was a cross-sectional study with retrospective data collection over a period of 7 years (January 1, 2010 to January 31, 2017). The data collected from the reports were socio-demographic characteristics, indications and lesions observed at colonoscopy. Binary logistic regression allowed us to identify the independent risk factors associated with the presence of tumors and polyps. 
  <b>Results:</b> We included 719 exams. The main indications were rectorrhagia (29.5%), abdominal pain (25.9%) and constipation (17.8%). A colonic lesion was found in 60.1% of cases. A colorectal tumor accounted for 10.3% of cases. Factors independently associated with colonic tumor were complete colonoscopy (aOR: 0.167 95% CI [0.096 - 0.289], p &lt; 0.001), presence of abdominal or rectal mass (aOR: 13.390 95% CI) [5.684 - 31.544], p &lt; 0.001) and weight loss (aOR: 5.143, 95% CI [2.450 - 10.797], p &lt; 0.001). 
  <b>Conclusion:</b> The presence of weight loss, abdominal or rectal mass should motivate the realization of a complete colonoscopy in search of a colorectal tumor. The most observed lesions remain hemorrhoids, polyps and diverticulosis of the colon.
 
</p></abstract><kwd-group><kwd>Colonoscopy</kwd><kwd> Indications</kwd><kwd> Colorectal Tumor</kwd><kwd> Limited Resources</kwd><kwd> Cameroon</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>The incidence of organic colonic disease is increasing in sub-Saharan Africa [<xref ref-type="bibr" rid="scirp.91698-ref1">1</xref>] . Colonoscopy allows visualization of the entire colonic mucosa [<xref ref-type="bibr" rid="scirp.91698-ref2">2</xref>] . Over time, its practice is more and more necessary and improvements are made to increase its profitability [<xref ref-type="bibr" rid="scirp.91698-ref3">3</xref>] . It is the case of narrow band imaging, which is used in combination with magnesium-enhanced endoscopy to better define precancerous colonic lesions [<xref ref-type="bibr" rid="scirp.91698-ref4">4</xref>] [<xref ref-type="bibr" rid="scirp.91698-ref5">5</xref>] . Thus, colonoscopy is the reference examination of colon exploration for the diagnosis, detection and surveillance of the main colon diseases [<xref ref-type="bibr" rid="scirp.91698-ref6">6</xref>] . It is also an invasive and expensive examination [<xref ref-type="bibr" rid="scirp.91698-ref7">7</xref>] . It is therefore important to determine, among its indications, those which lead to the most frequent diagnosis of neoplastic lesions [<xref ref-type="bibr" rid="scirp.91698-ref8">8</xref>] . Several studies have evaluated the proportion of colonoscopy reporting abnormalities in a given population (cost-effectiveness). In Cameroon, the yield is 51.3% [<xref ref-type="bibr" rid="scirp.91698-ref9">9</xref>] and reaches 71.9% in Sudan [<xref ref-type="bibr" rid="scirp.91698-ref10">10</xref>] . The indications for colonoscopy are varied. These include rectorrhagia, abdominal pain, transit changes, weight loss and many other indications. The major advantage of colonoscopy is the ability to perform diagnostic procedures such as sampling. Worldwide, gastrointestinal hemorrhage is the main indication for colonoscopy [<xref ref-type="bibr" rid="scirp.91698-ref1">1</xref>] [<xref ref-type="bibr" rid="scirp.91698-ref9">9</xref>] - [<xref ref-type="bibr" rid="scirp.91698-ref14">14</xref>] . In Cameroon, the main indications for colonoscopy are rectorrhagia (30.9%), abdominal pain (29.4%), chronic diarrhea (11.8%), chronic constipation (8.7%) [<xref ref-type="bibr" rid="scirp.91698-ref9">9</xref>] . However, all these indications do not always lead to the detection of digestive lesions. Colorectal cancer being the most feared lesion especially found in the subjects of more than 50 years [<xref ref-type="bibr" rid="scirp.91698-ref15">15</xref>] . In view of the risk incurred by patients, the cost of colonoscopy and increasing demand, it seems necessary to limit the indications for colonoscopy. In Africa and Cameroon in particular, colonoscopy is increasingly practiced [<xref ref-type="bibr" rid="scirp.91698-ref1">1</xref>] [<xref ref-type="bibr" rid="scirp.91698-ref9">9</xref>] [<xref ref-type="bibr" rid="scirp.91698-ref13">13</xref>] [<xref ref-type="bibr" rid="scirp.91698-ref16">16</xref>] [<xref ref-type="bibr" rid="scirp.91698-ref17">17</xref>] . Our objective was therefore to evaluate the yield of colonoscopy in lower digestive pathology by describing the indications and outcome in the endoscopy unit of Douala General Hospital.</p></sec><sec id="s2"><title>2. Methods</title><p>1) Study design, study area and setting</p><p>We conducted a cross-sectional study over a period of 7 years, from January 1, 2010 to January 31, 2017 at the digestive endoscopy unit of Douala General Hospital, a first-class health facility in the health pyramid. It is also a university hospital and has a capacity of 320 beds. The hospital has amongst other units an endoscopy exploratory unit, a gastroenterology outpatient consultation unit and an internal medicine service for hospitalization. Four senior gastroenterologists performed explorations in this unit with a Fujinon EPX-2200 video endoscope processor. Endoscopic examinations were performed by a video colonoscope Fujinon EC-201 WL. The disinfection procedure was performed manually according to the protocol of the French digestive endoscopy society [<xref ref-type="bibr" rid="scirp.91698-ref18">18</xref>] . Sedation was done with 10 mg of diazepam diluted in eight milliliters of saline and administered intravenously.</p><p>2) Data collection and analysis</p><p>Data was collected from the endoscopy reports. The following data were collected: age, sex, indication and lesions observed at colonoscopy.</p><p>All the colonoscopy reviews were included in this study. The yield of a colonoscopy was defined by its ability to highlight a particular lesion. Overall yield was determined by the number of colonoscopies revealing abnormalities compared to normal colonoscopies. It was considered complete any colonoscopy visualizing the colon until the caecum.</p><p>Data were analyzed using Statistical Package for Social Sciences 21.0. The results were expressed in numbers and percentages for the qualitative variables, mean and standard deviation for the quantitative variables. The chi-square test or the Fisher exact test was used for associations. The binary logistic regression allowed a multivariate analysis to find the factors independently associated with the significant lesions. Only factors associated with significant lesions in univariate analysis has been included in the logistic regression model to obtain adjusted odds ratio and p value. The threshold of significance was defined for a value p &lt; 0.05.</p><p>Ethics and consent: All information collected during this work has been treated confidentially. Data collection was retrospective and informed consent was not required. This study was approved by the institutional ethics committee of Douala General Hospital.</p></sec><sec id="s3"><title>3. Results</title><sec id="s3_1"><title>3.1. Population</title><p>We included 719 colonoscopy reports. The mean age was 51.9 &#177; 15.0 years, with a range of 5 to 88 years and a sex ratio of 1.3. Subjects older than 50 years accounted for 61.6% of the population. Complete colonoscopies were reported in 76.7% of cases.</p></sec><sec id="s3_2"><title>3.2. Indications for Colonoscopy</title><p>They have been grouped into three categories namely screening, monitoring and symptom evaluation. Rectorrhagia was the most common indication of colonoscopy accounting for 30% of the colonoscopies performed. <xref ref-type="table" rid="table1">Table 1</xref> summarizes the indications for colonoscopy.</p></sec><sec id="s3_3"><title>3.3. Observed Lesions</title><p>No lesions were found in 40% of colonoscopies. The three most common lesions were hemorrhoids (17.1%), diverticulosis (16.4%) and polyps (11.4%). The presence of colorectal tumor accounted for 10.3%.</p><p>The overall yield of the colonoscopy was 60.1%. <xref ref-type="table" rid="table2">Table 2</xref> summarizes the lesions observed at colonoscopy.</p><p>Factors associated with the presence of colorectal tumors</p><p>In univariate analysis the male gender (OR: 0.566, 95% CI [0.349 - 0.919]), performing a complete colonoscopy (OR: 0.184, 95% CI [0.111 - 0.302]), weight loss (OR: 3.317, 95% CI [1.713 - 6.421]) and the presence of an abdominal or rectal mass (OR: 8.537, 95% CI [4.011 - 18.170]) were significantly associated with the presence of a colorectal tumor. In binary logistic regression, the factors independently associated with the colorectal tumor were complete colonoscopy (adjusted OR: 0.167, 95% CI [0.096 - 0.289]), colorectal cancer surveillance (adjusted OR: 4.783, 95% CI [1.536 - 14.893]), weight loss (adjusted OR: 5.143 95% CI [2.450 - 10.797]) and abdominal or rectal mass (OR adjusted: 13.390 95% CI [5.684 - 31.544]). <xref ref-type="table" rid="table3">Table 3</xref> summarizes the factors associated with the presence of colorectal tumors.</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Indications for colonoscopy</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Indications</th><th align="center" valign="middle" >Numbers (n = 719)</th><th align="center" valign="middle" >Percentage (%)</th></tr></thead><tr><td align="center" valign="middle" >Screening</td><td align="center" valign="middle" >16</td><td align="center" valign="middle" >2.2</td></tr><tr><td align="center" valign="middle" >Positive hemocult</td><td align="center" valign="middle" >10</td><td align="center" valign="middle" >1.4</td></tr><tr><td align="center" valign="middle" >Family history of colorectal cancer</td><td align="center" valign="middle" >6</td><td align="center" valign="middle" >0.8</td></tr><tr><td align="center" valign="middle" >Surveillance</td><td align="center" valign="middle" >36</td><td align="center" valign="middle" >5.0</td></tr><tr><td align="center" valign="middle" >Colorectal cancer surveillance</td><td align="center" valign="middle" >21</td><td align="center" valign="middle" >2.9</td></tr><tr><td align="center" valign="middle" >Polyp monitoring</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" >1.1</td></tr><tr><td align="center" valign="middle" >Surveillance of ulcerative colitis</td><td align="center" valign="middle" >7</td><td align="center" valign="middle" >1.0</td></tr><tr><td align="center" valign="middle" >Symptom evaluation</td><td align="center" valign="middle" >661</td><td align="center" valign="middle" >92.7</td></tr><tr><td align="center" valign="middle" >Rectorrhagia</td><td align="center" valign="middle" >210</td><td align="center" valign="middle" >29.5</td></tr><tr><td align="center" valign="middle" >Abdominal pain</td><td align="center" valign="middle" >185</td><td align="center" valign="middle" >25.9</td></tr><tr><td align="center" valign="middle" >Constipation</td><td align="center" valign="middle" >127</td><td align="center" valign="middle" >17.8</td></tr><tr><td align="center" valign="middle" >Iron deficiency anemia</td><td align="center" valign="middle" >58</td><td align="center" valign="middle" >8.1</td></tr><tr><td align="center" valign="middle" >Weight loss</td><td align="center" valign="middle" >56</td><td align="center" valign="middle" >7.9</td></tr><tr><td align="center" valign="middle" >Diarrhea</td><td align="center" valign="middle" >39</td><td align="center" valign="middle" >5.5</td></tr><tr><td align="center" valign="middle" >Abdominal or rectal mass</td><td align="center" valign="middle" >31</td><td align="center" valign="middle" >4.3</td></tr><tr><td align="center" valign="middle" >Alternating diarrhea constipation</td><td align="center" valign="middle" >20</td><td align="center" valign="middle" >2.8</td></tr><tr><td align="center" valign="middle" >Proctalgia</td><td align="center" valign="middle" >20</td><td align="center" valign="middle" >2.8</td></tr><tr><td align="center" valign="middle" >Melena</td><td align="center" valign="middle" >13</td><td align="center" valign="middle" >1.8</td></tr><tr><td align="center" valign="middle" >Primary cancer foci search</td><td align="center" valign="middle" >12</td><td align="center" valign="middle" >1.7</td></tr><tr><td align="center" valign="middle" >Suspicion of CIBD</td><td align="center" valign="middle" >11</td><td align="center" valign="middle" >1.5</td></tr><tr><td align="center" valign="middle" >Other*</td><td align="center" valign="middle" >98</td><td align="center" valign="middle" >13.7</td></tr><tr><td align="center" valign="middle" >Unspecified</td><td align="center" valign="middle" >6</td><td align="center" valign="middle" >&lt;0.1</td></tr></tbody></table></table-wrap><p>*: Abdominal bloating, cervical cancer assessment, functional colopathy, dyspepsia, hemorrhoidal disease, dysenteric syndrome.</p><table-wrap id="table2" ><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> Lesions observed at colonoscopy</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Observed lesions</th><th align="center" valign="middle" >Numbers (n = 719)</th><th align="center" valign="middle" >Percentage (%)</th></tr></thead><tr><td align="center" valign="middle" >No lesion</td><td align="center" valign="middle" >287</td><td align="center" valign="middle" >39.9</td></tr><tr><td align="center" valign="middle" >Hemorrhoids</td><td align="center" valign="middle" >123</td><td align="center" valign="middle" >17.1</td></tr><tr><td align="center" valign="middle" >Diverticulosis</td><td align="center" valign="middle" >118</td><td align="center" valign="middle" >16.4</td></tr><tr><td align="center" valign="middle" >Polyp</td><td align="center" valign="middle" >82</td><td align="center" valign="middle" >11.4</td></tr><tr><td align="center" valign="middle" >Colorectal tumor</td><td align="center" valign="middle" >74</td><td align="center" valign="middle" >10.3</td></tr><tr><td align="center" valign="middle" >Colitis</td><td align="center" valign="middle" >39</td><td align="center" valign="middle" >5.4</td></tr><tr><td align="center" valign="middle" >Proctitis</td><td align="center" valign="middle" >28</td><td align="center" valign="middle" >3.9</td></tr><tr><td align="center" valign="middle" >Rectal ulcer</td><td align="center" valign="middle" >11</td><td align="center" valign="middle" >1.5</td></tr><tr><td align="center" valign="middle" >Other*</td><td align="center" valign="middle" >55</td><td align="center" valign="middle" >7.6</td></tr></tbody></table></table-wrap><p>*: colonic angiodysplasia, dolichocolon, spasmodic colopathy, erythema colic, fistula, melanosis colic.</p><table-wrap id="table3" ><label><xref ref-type="table" rid="table3">Table 3</xref></label><caption><title> Factors associated with the presence of colorectal tumor</title></caption><table><tbody><thead><tr><th align="center" valign="middle" ></th><th align="center" valign="middle" >Presence of colorectal tumor n (%)</th><th align="center" valign="middle" >Absence of colorectal tumor n (%)</th><th align="center" valign="middle" >Total n</th><th align="center" valign="middle" >OR (95% CI)</th><th align="center" valign="middle" >p-value</th><th align="center" valign="middle" >Adjusted OR (95% CI)</th><th align="center" valign="middle" >Adjusted p-value</th></tr></thead><tr><td align="center" valign="middle" >Age ≥ 50 years</td><td align="center" valign="middle" >47 (10.9)</td><td align="center" valign="middle" >385 (89.1)</td><td align="center" valign="middle" >432</td><td align="center" valign="middle" >1.141 (0.688 - 1.891)</td><td align="center" valign="middle" >0.607</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Male</td><td align="center" valign="middle" >33 (8.0)</td><td align="center" valign="middle" >378 (92.0)</td><td align="center" valign="middle" >411</td><td align="center" valign="middle" >0.566 (0.349 - 0.919)</td><td align="center" valign="middle" >0.021</td><td align="center" valign="middle" >0.630 (0.368 - 1.080)</td><td align="center" valign="middle" >0.093</td></tr><tr><td align="center" valign="middle" >Complete colonoscopy</td><td align="center" valign="middle" >32 (5.8)</td><td align="center" valign="middle" >519 (92.4)</td><td align="center" valign="middle" >551</td><td align="center" valign="middle" >0.184 (0.111 - 0.302)</td><td align="center" valign="middle" >&lt;0.001</td><td align="center" valign="middle" >0.167 (0.096 - 0.289)</td><td align="center" valign="middle" >&lt;0.001</td></tr><tr><td align="center" valign="middle" >Screening</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Positive hemocult</td><td align="center" valign="middle" >1 (10.0)</td><td align="center" valign="middle" >9 (90.0)</td><td align="center" valign="middle" >10</td><td align="center" valign="middle" >0.959 (0.120 - 7.677)</td><td align="center" valign="middle" >1.000</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Family history of colorectal cancer</td><td align="center" valign="middle" >0 (0)</td><td align="center" valign="middle" >6 (100)</td><td align="center" valign="middle" >6</td><td align="center" valign="middle" >/</td><td align="center" valign="middle" >1.000</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Surveillance</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Colorectal cancer surveillance</td><td align="center" valign="middle" >5 (23.8)</td><td align="center" valign="middle" >16 (76.2)</td><td align="center" valign="middle" >21</td><td align="center" valign="middle" >2.822 (1.003 - 7.939)</td><td align="center" valign="middle" >0.057</td><td align="center" valign="middle" >4.783 (1.536 - 14.893)</td><td align="center" valign="middle" >0.007</td></tr><tr><td align="center" valign="middle" >Polyp monitoring</td><td align="center" valign="middle" >0 (0)</td><td align="center" valign="middle" >8 (100)</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" >/</td><td align="center" valign="middle" >1.000</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Surveillance of ulcerative colitis</td><td align="center" valign="middle" >0 (0)</td><td align="center" valign="middle" >7 (100.0)</td><td align="center" valign="middle" >7</td><td align="center" valign="middle" >/</td><td align="center" valign="middle" >1.000</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Symptom evaluation</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Rectorrhagia</td><td align="center" valign="middle" >25 (11.9)</td><td align="center" valign="middle" >185 (88.1)</td><td align="center" valign="middle" >210</td><td align="center" valign="middle" >1.252 (0.751 - 2.087)</td><td align="center" valign="middle" >0.393</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Abdominal pain</td><td align="center" valign="middle" >15 (8.0)</td><td align="center" valign="middle" >173 (92.0)</td><td align="center" valign="middle" >188</td><td align="center" valign="middle" >0.685 (0.378 - 1.239)</td><td align="center" valign="middle" >0.197</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Constipation</td><td align="center" valign="middle" >11 (8.7)</td><td align="center" valign="middle" >116 (91.3)</td><td align="center" valign="middle" >127</td><td align="center" valign="middle" >0.787 (0.402 - 1.540)</td><td align="center" valign="middle" >0.475</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Iron deficiency anemia</td><td align="center" valign="middle" >5 (8.6)</td><td align="center" valign="middle" >53 (91.4)</td><td align="center" valign="middle" >58</td><td align="center" valign="middle" >0.801(0.310 - 2.072)</td><td align="center" valign="middle" >0.639</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Emaciation</td><td align="center" valign="middle" >14 (25.0)</td><td align="center" valign="middle" >42 (75.0)</td><td align="center" valign="middle" >56</td><td align="center" valign="middle" >3.317 (1.713 - 6.421)</td><td align="center" valign="middle" >0.001</td><td align="center" valign="middle" >5.143 (2.450 - 10.797)</td><td align="center" valign="middle" >&lt;0.001</td></tr><tr><td align="center" valign="middle" >Diarrhea</td><td align="center" valign="middle" >6 (15.4)</td><td align="center" valign="middle" >33 (84.6)</td><td align="center" valign="middle" >39</td><td align="center" valign="middle" >1.620 (0.655 - 4.006)</td><td align="center" valign="middle" >0.280</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Abdominal or rectal mass</td><td align="center" valign="middle" >14 (45.2)</td><td align="center" valign="middle" >17 (54.8)</td><td align="center" valign="middle" >31</td><td align="center" valign="middle" >8.537 (4.011 - 18.170)</td><td align="center" valign="middle" >&lt;0.001</td><td align="center" valign="middle" >13.390 (5.684 - 31.544)</td><td align="center" valign="middle" >&lt;0.001</td></tr><tr><td align="center" valign="middle" >Alternating diarrhea constipation</td><td align="center" valign="middle" >1 (5.0)</td><td align="center" valign="middle" >19 (95.0)</td><td align="center" valign="middle" >20</td><td align="center" valign="middle" >0.447 (0.059 - 3.388)</td><td align="center" valign="middle" >0.711</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Proctalgia</td><td align="center" valign="middle" >2 (10.0)</td><td align="center" valign="middle" >18 (90.0)</td><td align="center" valign="middle" >20</td><td align="center" valign="middle" >0.958 (0.218 - 4.215)</td><td align="center" valign="middle" >1.000</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Melena</td><td align="center" valign="middle" >1 (7.7)</td><td align="center" valign="middle" >12 (92.3)</td><td align="center" valign="middle" >13</td><td align="center" valign="middle" >0.716 (0.092 - 5.584)</td><td align="center" valign="middle" >1.000</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr></tbody></table></table-wrap><p>For polyps, univariate analysis revealed the following significantly associated factors: complete colonoscopy (OR: 2.360, 95% CI [1.189 - 4.684]), colorectal cancer surveillance (OR: 3.242 95% CI [1.221 - 8.606]), polyp (OR: 58.800, 95% CI [7.136 - 484.474]) and ulcerative colitis (OR: 5.953, 95% CI [1.308 - 27.084]) and diarrhea. In multivariate analysis, the factors independently associated with the presence of polyps were the same as those mentioned above with the exception of diarrhea. <xref ref-type="table" rid="table4">Table 4</xref> summarizes the factors associated with the presence of polyps.</p></sec></sec><sec id="s4"><title>4. Discussion</title><p>The aim of this work was to evaluate the yield of colonoscopy in lower digestive pathology according to indications. We report the results of 719 colonoscopies</p><table-wrap id="table4" ><label><xref ref-type="table" rid="table4">Table 4</xref></label><caption><title> Factors associated with the presence of polyps</title></caption><table><tbody><thead><tr><th align="center" valign="middle" ></th><th align="center" valign="middle" >Presence of polyp n (%)</th><th align="center" valign="middle" >Absence of polyp n (%)</th><th align="center" valign="middle" >Total n</th><th align="center" valign="middle" >OR (95% CI)</th><th align="center" valign="middle" >p value</th><th align="center" valign="middle" >Adjusted OR (95% CI)</th><th align="center" valign="middle" >Adjusted p value</th></tr></thead><tr><td align="center" valign="middle" >Age ≥ 50 years</td><td align="center" valign="middle" >52 (12.0)</td><td align="center" valign="middle" >380 (88.0)</td><td align="center" valign="middle" >432</td><td align="center" valign="middle" >1.132 (0.699 - 1.834)</td><td align="center" valign="middle" >0.611</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Male</td><td align="center" valign="middle" >54 (13.1)</td><td align="center" valign="middle" >357 (86.9)</td><td align="center" valign="middle" >411</td><td align="center" valign="middle" >1.507 (0.930 - 2.442)</td><td align="center" valign="middle" >0.091</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Complete colonoscopy</td><td align="center" valign="middle" >72 (13.1)</td><td align="center" valign="middle" >479 (86.9)</td><td align="center" valign="middle" >551</td><td align="center" valign="middle" >2.360 (1.189 - 4.684)</td><td align="center" valign="middle" >0.007</td><td align="center" valign="middle" >2.099 (1.048 - 4.205)</td><td align="center" valign="middle" >0.036</td></tr><tr><td align="center" valign="middle" >Screening</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Positive hemocult</td><td align="center" valign="middle" >3 (30.0)</td><td align="center" valign="middle" >7 (70.0)</td><td align="center" valign="middle" >10</td><td align="center" valign="middle" >3.385 (0.858 - 13.357)</td><td align="center" valign="middle" >0.097</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Family history of colorectal cancer</td><td align="center" valign="middle" >1 (16.7)</td><td align="center" valign="middle" >5 (83.3)</td><td align="center" valign="middle" >6</td><td align="center" valign="middle" >1.546 (0.178 - 13.396)</td><td align="center" valign="middle" >0.521</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Surveillance</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Colorectal cancer surveillance</td><td align="center" valign="middle" >6 (28.6)</td><td align="center" valign="middle" >15 (71.4)</td><td align="center" valign="middle" >21</td><td align="center" valign="middle" >3.242 (1.221 - 8.606)</td><td align="center" valign="middle" >0.025</td><td align="center" valign="middle" >3.632 (1.354 - 9.742)</td><td align="center" valign="middle" >0.010</td></tr><tr><td align="center" valign="middle" >Polyp monitoring</td><td align="center" valign="middle" >7 (87.5)</td><td align="center" valign="middle" >1 (12.5)</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" >58.800 (7.136 - 484.474)</td><td align="center" valign="middle" >&lt;0.001</td><td align="center" valign="middle" >56.255 (6.799 - 465.437)</td><td align="center" valign="middle" >&lt;0.001</td></tr><tr><td align="center" valign="middle" >Surveillance of ulcerative colitis</td><td align="center" valign="middle" >3 (42.9)</td><td align="center" valign="middle" >4 (57.1)</td><td align="center" valign="middle" >7</td><td align="center" valign="middle" >5.953 (1.308 - 27.084)</td><td align="center" valign="middle" >0.036</td><td align="center" valign="middle" >6.652 (1.441 - 30.700)</td><td align="center" valign="middle" >0.015</td></tr><tr><td align="center" valign="middle" >Symptom evaluation</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Rectorrhagia</td><td align="center" valign="middle" >23 (11.0)</td><td align="center" valign="middle" >187 (89.0)</td><td align="center" valign="middle" >210</td><td align="center" valign="middle" >0.926 (0.555 - 1.543)</td><td align="center" valign="middle" >0.766</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Abdominal pain</td><td align="center" valign="middle" >16 (8.5)</td><td align="center" valign="middle" >172 (91.5)</td><td align="center" valign="middle" >188</td><td align="center" valign="middle" >0.647 (0.365 - 1.148)</td><td align="center" valign="middle" >0.124</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Constipation</td><td align="center" valign="middle" >17 (13.4)</td><td align="center" valign="middle" >110 (86.6)</td><td align="center" valign="middle" >127</td><td align="center" valign="middle" >1.239 (0.699 - 2.195)</td><td align="center" valign="middle" >0.470</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Iron deficiency anemia</td><td align="center" valign="middle" >5 (8.6)</td><td align="center" valign="middle" >53 (91.4)</td><td align="center" valign="middle" >58</td><td align="center" valign="middle" >0.708 (0.275 - 1.826)</td><td align="center" valign="middle" >0.457</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Weight loss</td><td align="center" valign="middle" >7 (12.5)</td><td align="center" valign="middle" >49 (87.5)</td><td align="center" valign="middle" >56</td><td align="center" valign="middle" >1.109 (0.485 - 2.536)</td><td align="center" valign="middle" >0.809</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Diarrhea</td><td align="center" valign="middle" >0 (0)</td><td align="center" valign="middle" >39 (100)</td><td align="center" valign="middle" >39</td><td align="center" valign="middle" >/</td><td align="center" valign="middle" >0.016</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Abdominal or rectal mass</td><td align="center" valign="middle" >2 (6.5)</td><td align="center" valign="middle" >29 (93.5)</td><td align="center" valign="middle" >31</td><td align="center" valign="middle" >0.519 (0.122 - 2.216)</td><td align="center" valign="middle" >0.565</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Alternating diarrhea constipation</td><td align="center" valign="middle" >1 (5.0)</td><td align="center" valign="middle" >19 (95.0)</td><td align="center" valign="middle" >20</td><td align="center" valign="middle" >0.398 (0.053 - 3.010)</td><td align="center" valign="middle" >0.718</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Proctalgia</td><td align="center" valign="middle" >0 (0)</td><td align="center" valign="middle" >20 (100)</td><td align="center" valign="middle" >20</td><td align="center" valign="middle" >/</td><td align="center" valign="middle" >0.152</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Melena</td><td align="center" valign="middle" >1 (7.7)</td><td align="center" valign="middle" >12 (92.3)</td><td align="center" valign="middle" >13</td><td align="center" valign="middle" >0.637 (0.082 - 4.962)</td><td align="center" valign="middle" >0.647</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr></tbody></table></table-wrap><p>performed in the digestive endoscopy unit of Douala General Hospital in Cameroon. These have made it possible to identify in 432 cases an injury, thus a yield of 60%. In a study conducted in the city of Yaound&#233;, Ankouane et al. reported a yield of 51.3% [<xref ref-type="bibr" rid="scirp.91698-ref9">9</xref>] . In Nigeria, it was 79.6% [<xref ref-type="bibr" rid="scirp.91698-ref13">13</xref>] , in Senegal 61.9% [<xref ref-type="bibr" rid="scirp.91698-ref1">1</xref>] . In Europe, Exbrayat and Kmieciak reported yield of 31.9% and 43%, respectively [<xref ref-type="bibr" rid="scirp.91698-ref6">6</xref>] [<xref ref-type="bibr" rid="scirp.91698-ref7">7</xref>] . These high rates generally in Africa reflect the fact that colonoscopies are most often performed in subjects already having digestive symptoms. However, the variations observed in the different values would be related to several factors such as the nature of the selected colonoscopies. Colonoscopy indications are varied and found in various proportions depending on the series. In ours, the most common were those related to the evaluation of digestive symptoms accounting for 92.7% of indications. Ankouane et al. found 90.1% of indications related to the evaluation of digestive symptoms. This rate is relatively low in the West, so Exbrayat et al. in a series of 1779 colonoscopies reported a proportion of 40% in this group of indications [<xref ref-type="bibr" rid="scirp.91698-ref7">7</xref>] . Screening in healthy subjects and coverage by insurance coverage in the West makes it possible and justify this disparity. The most common symptoms leading to colonoscopy were rectal bleeding (29.5%), abdominal pain (25.9%), constipation (17.8%), iron deficiency anemia (8.1%), weight loss (7.9%). In Yaound&#233;, it was mainly rectorrhagia (30.9%), abdominal pain (29.4%), chronic diarrhea (11.8%), chronic constipation (8.7%), iron deficiency anemia (3.0%) [<xref ref-type="bibr" rid="scirp.91698-ref9">9</xref>] . In Nigeria, Adegboyega et al. found rectorrhagia (34%), abdominal pain (18.4%), constipation (10.8%), diarrhea (8.8%) and changes in transit (3.6%) [<xref ref-type="bibr" rid="scirp.91698-ref12">12</xref>] . In America, Lieberman et al. found mainly rectal bleeding (33.6%) and symptoms suggestive of irritable bowel (23.8%) [<xref ref-type="bibr" rid="scirp.91698-ref11">11</xref>] . Digestive bleeding at the international level is the main indication of colonoscopy certainly because of the alarming nature of this sign for both the clinician and the patient. Screening was the indication for colonoscopy in 2.2% of cases in our series with 10 cases (1.4%) of positive blood cultures and 6 cases (0.8%) of family history of colorectal cancer. Ankouane et al. reported 3.1% of colonoscopies in this indication with 13 cases (1.4%) of positive blood cultures [<xref ref-type="bibr" rid="scirp.91698-ref9">9</xref>] . In Senegal, screening for colorectal cancer accounts for 2.65% of colonoscopy indications [<xref ref-type="bibr" rid="scirp.91698-ref1">1</xref>] . In Europe, Kmieciak reported 22% colorectal cancer screening and in America, Lieberman reported 35.2% colorectal cancer screening [<xref ref-type="bibr" rid="scirp.91698-ref6">6</xref>] [<xref ref-type="bibr" rid="scirp.91698-ref11">11</xref>] . In sub-Saharan Africa, there are several barriers to access to care, mainly financial precariousness, the lack of information for subjects at risk of colorectal cancer. In addition, screening is very rare [<xref ref-type="bibr" rid="scirp.91698-ref1">1</xref>] [<xref ref-type="bibr" rid="scirp.91698-ref9">9</xref>] . This inequality also helps to understand the relatively high proportion of subjects over 50 in western series compared to African series [<xref ref-type="bibr" rid="scirp.91698-ref7">7</xref>] [<xref ref-type="bibr" rid="scirp.91698-ref9">9</xref>] [<xref ref-type="bibr" rid="scirp.91698-ref11">11</xref>] [<xref ref-type="bibr" rid="scirp.91698-ref13">13</xref>] [<xref ref-type="bibr" rid="scirp.91698-ref19">19</xref>] because it is established that colorectal cancer occurs mainly after age of 50 [<xref ref-type="bibr" rid="scirp.91698-ref15">15</xref>] . The colonic lesions monitoring accounted for 5% of our indications. In Yaound&#233;, it represented 2.9%, in Europe 22% and in America 21.7%.</p></sec><sec id="s5"><title>5. Conclusion</title><p>The interest of the practice of colonoscopy in sub-Saharan Africa is essentially focused on the evaluation of symptoms. It allows in significant proportions to highlight significant colonic lesions, namely colorectal tumors and polyps. The indications independently associated with the colorectal tumor are the completion of a complete colonoscopy, the presence of abdominal mass and weight loss. Therefore, the presence of weight loss, abdominal or rectal mass should motivate the realization of a complete colonoscopy in search of a colorectal tumor. The most observed lesions remain hemorrhoids, polyps and diverticulosis of the colon.</p></sec><sec id="s6"><title>Acknowledgements</title><p>Medical and paramedical staff of digestive endoscopy unit of Douala General Hospital.</p></sec><sec id="s7"><title>Funding</title><p>None.</p></sec><sec id="s8"><title>Contribution of Authors</title><p>Conception of the study: Gabin Ulrich Kenfack and S.A. Eloumou Bagnaka.</p><p>Data collection and analysis: Gabin Ulrich Kenfack and Guy Sadeu Wafeu.<sup> </sup></p><p>Redaction: Gabin Ulrich Kenfack, S.A. Eloumou Bagnaka, Guy Sadeu Wafeu and Paul Nkemtendong Tolefac.</p><p>Relecture and supervision: Gabin Ulrich Kenfack, S.A. Eloumou Bagnaka, Winnie Bekolo, Guy Sadeu Wafeu, Paul Nkemtendong Tolefac, A. Malongue, Mathurin Pierre Kowo, C. Tzeuton, F Ankouane Andoulo, Oudou Njoya, H. Luma Namme and D. Noah Noah.</p><p>All authors read and approved the final manuscript.</p></sec><sec id="s9"><title>Conflicts of Interest</title><p>Authors declare that they have no competing interests.</p></sec><sec id="s10"><title>Cite this paper</title><p>Kenfack, G.U., Eloumou, S.A.F.B., Nga, W.T.B., Wafeu, G.S., Tolefac, P.N., Malongue, A., Kowo, M.P., Tzeuton, C., Andoulo, F.A., Njoya, O., Luma, H.N. and Noah, D.N. (2019) Indications, Yield and Outcome of Colonoscopy: A 7-Year Retrospective Study in a Resource-Limited Setting. Open Journal of Gastroenterology, 9, 49-58. https://doi.org/10.4236/ojgas.2019.93008</p></sec></body><back><ref-list><title>References</title><ref id="scirp.91698-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Mbengue, M., Dia, D., Diouf, M.L., Bassene, M.L. and Halim, A. (2010) Practice of Colonoscopy in Africa, Analysis of 376 Examinations in Dakar, Senegal. Médecine d’Afrique Noire Electronique, 57, 508-512.</mixed-citation></ref><ref id="scirp.91698-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">JFHOD|SNFGE.org. French Scientific Society of Hepatogastroenterology and Digestive Oncology. https://www.snfge.org/content/prevalence-des-polypes-coliques-lors-de-la-colo</mixed-citation></ref><ref id="scirp.91698-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Puente, D., Cantero, F.X., Llagostera, M., Pi&amp;#241;eiro, P., Nieto, R., Saladich, R., et al. (2012) A Cross-Sectional Study of the Appropriateness of Colonoscopy Requests in the Spanish Region of Catalonia. BMJ Open, 2, e002207. https://doi.org/10.1136/bmjopen-2012-002207</mixed-citation></ref><ref id="scirp.91698-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Iwatate, M., Ikumoto, T., Hattori, S., Sano, W., Sano, Y. and Fujimori, T. (2012) NBI and NBI Combined with Magnifying Colonoscopy. Diagnostic and Therapeutic Endoscopy, 2012, Article ID: 173269. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3523539</mixed-citation></ref><ref id="scirp.91698-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Vi&amp;#351;ovan, I.I., Tan&amp;#539;&amp;#259;u, M., Pascu, O., Ciobanu, L. and Tan&amp;#539;&amp;#259;u, A. (2017) The Role of Narrow Band Imaging in Colorectal Polyp Detection. Bosnian Journal of Basic Medical Sciences, 17, 152-158.</mixed-citation></ref><ref id="scirp.91698-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Kmieciak Le Corguillé, M., Gaudric, M., Sogni, P., Roche, H., Brézault, C., et al. (2003) Relevance of Colonoscopy Indications in an AP-HP Gastroenterology Department in 2001. Application of Criteria Established by a Panel of European Experts. Gastroentérologie Clinique et Biologique, 27, 213-218.</mixed-citation></ref><ref id="scirp.91698-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Exbrayat, C., Garnier, A., Billette de Villemeur, A., Winckel, P., Fournet, J., Bureau Du Colombier, P., Bolla, M. and Jestin, C. (2002) Results of Colocopies According to Their Indications and Consequences for the Detection of Polyps and Colorectal Cancers. Masson, Paris.</mixed-citation></ref><ref id="scirp.91698-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Arditi, C., Peytremann-Bridevaux, I., Burnand, B., Eckardt, V.F., Bytzer, P., Agréus, L., et al. (2009) Appropriateness of Colonoscopy in Europe (EPAGE II). Screening for Colorectal Cancer. Endoscopy, 41, 200-208. https://doi.org/10.1055/s-0028-1119626</mixed-citation></ref><ref id="scirp.91698-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Andoulo, F.A., Kowo, M., Nonga, B.N., Djapa, R., Sartre, M.T., Njoya, O., et al. (2016) Indications, Results and Performance of Colonoscopy in an Unfavorable Economic Environment: The Case of Cameroon. Human Health and Disease, 14, 1-6.</mixed-citation></ref><ref id="scirp.91698-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Doumi, E.A., Adam, H.Y. and Hamad, A.M. (2014) Colonoscopy at El Obeid Hospital, Western Sudan. Journal of Medical Sciences, 9, 107-110.</mixed-citation></ref><ref id="scirp.91698-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Lieberman, D.A., Holub, J., Eisen, G., Kraemer, D. and Morris, C.D. (2005) Utilization of Colonoscopy in the United States: Results from a National Consortium. Gastrointestinal Endoscopy, 62, 875-883. https://doi.org/10.1016/j.gie.2005.06.037</mixed-citation></ref><ref id="scirp.91698-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Akere, A., Oke, T.O. and Otegbayo, J.A. (2016) Colonoscopy at a Tertiary Healthcare Facility in Southwest Nigeria: Spectrum of Indications and Colonic Abnormalities. Annals of African Medicine, 15, 109. https://doi.org/10.4103/1596-3519.188889</mixed-citation></ref><ref id="scirp.91698-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Olokoba, A.B., Obateru, O.A., Bojuwoye, M.O., Olatoke, S.A., Bolarinwa, O.A. and Olokoba, L.B. (2013) Indications and Findings at Colonoscopy in Ilorin, Nigeria. Nigerian Medical Journal: Journal of the Nigeria Medical Association, 54, 111-114. https://doi.org/10.4103/0300-1652.110044</mixed-citation></ref><ref id="scirp.91698-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Corguillé, M.K.L., Gaudric, M., Sogni, P., Roche, H., Brézault, C., Dieumegard, B., et al. (2008) Relevance of Colonoscopy Indications in an AP-HP Gastroenterology Department in 2001. http://www.emconsulte.com/en/article/99427</mixed-citation></ref><ref id="scirp.91698-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Fleshner, P., Slater, G. and Aufses, A.H. (1989) Age and Sex Distribution of Patients with Colorectal Cancer. Diseases of the Colon &amp; Rectum, 32, 107-111. https://doi.org/10.1007/BF02553821</mixed-citation></ref><ref id="scirp.91698-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Ndjitiyap Ndam, E.C., Njoya, O., Mballa, E., Nsangou, M.F., Njapom, C., Moukouri Nyolo, E., et al. (1991) Contribution of the Endoscopy in the Digestive Pathology Low in Cameroonian Environment. Analytical Study of 720 Exams. Médecine d’Afrique Noire Electronique, 38, 835-839.</mixed-citation></ref><ref id="scirp.91698-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Assi, C., Lohouès-Kouacou, M.J., Allah-Kouadio, E., Njossu, C.J., Okon, A.J.-B., Doffou, S., et al. (2012) Appropriateness of Colonoscopy in Cocody Teaching Hospital Center in 2010: A Prospective Study Using Criteria Established by the European Panel on the Appropriateness of Gastrointestinal Endoscopy (EPAGE). Open Journal of Gastroenterology, 2, 193. https://doi.org/10.4236/ojgas.2012.24039</mixed-citation></ref><ref id="scirp.91698-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Endoscopie Colo-Rectale|SFED. http://www.sfed.org/professionnels/recommandations-et-autres-fiches/lesrecommandations/endoscopie-colo-rectale</mixed-citation></ref><ref id="scirp.91698-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">Lieberman, D.A., Williams, J.L., Holub, J.L., Morris, C.D., Logan, J.R., Eisen, G.M., et al. (2014) Colonoscopy Utilization and Outcomes 2000 to 2011. Gastrointestinal Endoscopy, 80, 133-143. https://doi.org/10.1016/j.gie.2014.01.014</mixed-citation></ref></ref-list></back></article>